Drug shortages are a persistent public health issue in the US. There is no easy method to scale up production to meet periodic sharp increases in demand, like the one occurring at the moment as a result of the "tripledemic." And there is a limited profit motive to do so, particularly for generics.
Subscribe to:
Post Comments (Atom)
< + > At HIMSS25, eClinicalWorks will focus on practical applications of AI
The vendor will be introducing ambient listening and medical scribe technologies, and will showcase artificial intelligence that extracts da...
-
Welcome to the weekly edition of Healthcare IT Today Bonus Features . This article will be a weekly roundup of interesting stories, product ...
-
It can be very overwhelming scrolling though job board after job board in search of a position that fits your wants and needs. Let us take t...
-
As we wrap up another year and get ready for 2025 to begin, it is once again time for everyone’s favorite annual tradition of Health IT Pred...
No comments:
Post a Comment